FD to stand trial
What do you get if you cross a dodgy FD with a couple of fishy lawyers – some insider trading perhaps? Neutec Pharma PLC’s finance director, Peter King, faces trial for insider dealing charges brough by the FSA. The FSA accused him of disclosing information relating to the proposed takeover of Neutec Pharma PLC in June 2006 by Swiss drugsmaker Novartis AG.
King is accused of handing info to a lawyer from McDermott Will & Emery, Michael McFall, who was charged …
What do you get if you cross a dodgy FD with a couple of fishy lawyers – some insider trading perhaps?
Neutec Pharma PLC’s finance director, Peter King, faces trial for insider dealing charges brough by the FSA. The FSA accused him of disclosing information relating to the proposed takeover of Neutec Pharma PLC in June 2006 by Swiss drugsmaker Novartis AG.
King is accused of handing info to a lawyer from McDermott Will & Emery, Michael McFall, who was charged with acting on that information to buy shares in the company and disclosing the information to another lawyer from Dorsey & Whitney, Andrew Rimmington, who also bought shares on the basis of the inside information.
A case management hearing will be held at Southwark Crown Court on 28 October.
Lawyers committed to stand trial for insider dealing
[SolicitR]
